Autoantibodies Signal Reduced Cancer Risk in Dermatomyositis
In patients with dermatomyositis positive for anti-TIF1-γ autoantibodies, the presence of anti-CCAR1 autoantibodies indicate normal rather than elevated cancer risk.
Medscape Medical News
source https://www.medscape.com/viewarticle/988424?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/988424?src=rss
Comments
Post a Comment